Optimisation of rheumatology indices: Dactylitis and enthesitis in psoriatic arthritis

Clinical and Experimental Rheumatology

Volumn 32, Issue , 2014, Pages S113-S117

  Ferguson, Esme G ^a   Coates, Laura C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Clinical assessment; Dactylitis; Enthesitis; Outcome measures; Psoriatic arthritis

Indexed keywords

CERTOLIZUMAB PEGOL; GOLIMUMAB; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ARTICLE; COMPOSITE PSORIATIC DISEASE ACTIVITY INDEX; DACTYLITIS; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; ENTHESITIS; HUMAN; LEEDS ENTHESITIS INDEX; MAASTRICT ANKYLOSING SPONDYLITIS ENTHESITIS SCORE; MANDER ENTHESITIS INDEX; MUSCULOSKELETAL DISEASE ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; ARTHRALGIA; ARTHRITIS, PSORIATIC; COMPLICATION; DIAGNOSTIC IMAGING; DISABILITY; FINGER; HEALTH CARE QUALITY; HEALTH STATUS; HEALTH STATUS INDICATOR; INFLAMMATION; OUTCOME ASSESSMENT; PAIN MEASUREMENT; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX; STANDARDS;

ARTHRALGIA; ARTHRITIS, PSORIATIC; DIAGNOSTIC IMAGING; DISABILITY EVALUATION; FINGERS; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; INFLAMMATION; PAIN MEASUREMENT; PATIENT OUTCOME ASSESSMENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUALITY INDICATORS, HEALTH CARE; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 84922407646     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. TAYLOR W, GLADMAN D, HELLIWELL P et al.: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-73.
2. COATES LC, CONAGHAN PG, EMERY P et al.: Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2012; 64: 3150-5.
3. GLADMAN DD, MEASE PJ, STRAND V et al.: Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007; 34: 1167-70.
4. McGONAGLE D, LORIES RJ, TAN AL, BENJAMIN M: The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 2007; 56: 2482-91.
5. GLADMAN DD, CHANDRAN V: Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 2011; 50: 25-31.
6. MARZO-ORTEGA H, McGONAGLE D, O'CONNOR P, EMERY P.: Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study. [see comment]. Arthritis Rheum 2001; 44: 2112-7.
7. D'AGOSTINO MA, SAID-NAHAL R, HACQUARD-BOUDER C, BRASSEUR JL, DOUGADOS M, BREBAN M: Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 2003; 48: 523-33.
8. McQUEEN FM, GAO A, OSTERGAARD M et al.: High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone. Ann Rheum Dis 2007; 66: 1581-7.
9. EDER L, JAYAKAR J, THAVANESWARAN A et al.: Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? J Rheumatol 2014; 41: 466-72.
10. BALINT PV, KANE D, WILSON H, McINNES IB, STURROCK RD et al.: Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 2002; 61: 905-10.
11. MANDER M, SIMPSON JM, McLELLAN A, WALKER D, GOODACRE JA, DICK WC: Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 1987; 46: 197-202.
12. HEUFT-DORENBOSCH L, SPOORENBERG A, VAN TUBERGEN A et al.: Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003; 62: 127-32.
13. GLADMAN DD, INMAN RD, COOK RJ et al.: International spondyloarthritis interobserver reliability exercise-the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol 2007; 34: 1740-5.
14. KAVANAUGH A, McINNES I, MEASE P, et al.: Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebocontrolled study. Arthritis Rheum 2009; 60: 976-86.
15. KAVANAUGH A, MEASE P: Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL). J Rheumatol 2012; 89 (Suppl.): 90-3.
16. MAKSYMOWYCH WP, MALLON C, MORROW S et al.: Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 2009; 68: 948-53.
17. HEALY PJ, HELLIWELL PS: Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 2008; 59: 686-91.
18. MEASE PJ, FLEISCHMANN R, DEODHAR AA et al.: Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 doubleblind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis 2014; 73: 48-55.
19. OLIVIERI I, BAROZZI L, FAVARO L et al.: Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum 1996; 39: 1524-8.
20. GLADMAN DD, COOK RJ, SCHENTAG C et al.: The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol 2004; 31: 1126-31.
21. FUCHS HA, BROOKS RH, CALLAHAN LF, PINCUS T: A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 1989; 32: 531-7.
22. HELLIWELL PS, FIRTH J, IBRAHIM GH, MELSOM RD, SHAH I, TURNER DE: Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005; 32: 1745-50.
23. HEALY PJ, HELLIWELL PS: Measuring dactylitis in clinical trials: which is the best instrument to use? J Rheumatol 2007; 34: 1302-6.
24. HEALY P, GROVES C, CHANDRAMOHAN M, HELLIWELL PS: MRI changes in psoriatic dactylitis-extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology (Oxford) 2008; 47: 92-5.
25. MUMTAZ A, GALLAGHER P, KIRBY B et al.: Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 2011; 70: 272-7.
26. EBERL G, STUDNICKA-BENKE A, HITZELHAMMER H, GSCHNAIT F, SMOLEN JS: Development of a disease activity index for the assessment of reactive arthritis (DAREA). Rheumatology (Oxford) 2000; 39: 148-55.
27. FitzGERALD O, HELLIWELL P, MEASE P et al.: Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set. Ann Rheum Dis 2012; 71: 358-62.
28. HELLIWELL PS, FitzGERALD O, MEASE PJ: Development of composite measures for psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol 2012; 39: 398-403.
29. HELLIWELL PS, KAVANAUGH A: Comparison of composite measures of disease activity in psoriatic arthritis using data from an interventional study with golimumab. Arthritis Care Res (Hoboken) 2014; 66: 749-56.
30. COATES LC, HELLIWELL PS: Disease measurement-enthesitis, skin, nails, spine and dactylitis. Best Pract Res Clin Rheumatol 2010; 24: 659-70.